HK1040945A1 - 包含曲馬多物質和選擇性cox-2抑制劑藥物的組合物 - Google Patents

包含曲馬多物質和選擇性cox-2抑制劑藥物的組合物

Info

Publication number
HK1040945A1
HK1040945A1 HK02102940.5A HK02102940A HK1040945A1 HK 1040945 A1 HK1040945 A1 HK 1040945A1 HK 02102940 A HK02102940 A HK 02102940A HK 1040945 A1 HK1040945 A1 HK 1040945A1
Authority
HK
Hong Kong
Prior art keywords
composition
selective cox
inhibitor drug
tramadol material
tramadol
Prior art date
Application number
HK02102940.5A
Other languages
English (en)
Chinese (zh)
Inventor
E Codd Ellen
P Martinez Rebecca
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HK1040945A1 publication Critical patent/HK1040945A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02102940.5A 1999-03-01 2002-04-18 包含曲馬多物質和選擇性cox-2抑制劑藥物的組合物 HK1040945A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12202699P 1999-03-01 1999-03-01
PCT/US2000/005119 WO2000051685A1 (en) 1999-03-01 2000-02-29 Composition comprising a tramadol material and a selective cox-2 inhibitor drug

Publications (1)

Publication Number Publication Date
HK1040945A1 true HK1040945A1 (zh) 2002-06-28

Family

ID=22400139

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102940.5A HK1040945A1 (zh) 1999-03-01 2002-04-18 包含曲馬多物質和選擇性cox-2抑制劑藥物的組合物

Country Status (9)

Country Link
EP (1) EP1156855A1 (ja)
JP (1) JP2002538176A (ja)
CN (1) CN1349423A (ja)
AU (1) AU3384200A (ja)
CA (1) CA2364127A1 (ja)
HK (1) HK1040945A1 (ja)
MX (1) MXPA01008903A (ja)
NZ (1) NZ513924A (ja)
WO (1) WO2000051685A1 (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795332B2 (en) 2002-09-30 2014-08-05 Ethicon, Inc. Barbed sutures
CA2348979A1 (en) * 1998-11-02 2000-05-11 Merck & Co., Inc. Method of treating migraines and pharmaceutical compositions
WO2003048113A1 (en) 2001-11-30 2003-06-12 Sepracor Inc. Tramadol analogs and uses thereof
US6773450B2 (en) 2002-08-09 2004-08-10 Quill Medical, Inc. Suture anchor and method
US8100940B2 (en) 2002-09-30 2012-01-24 Quill Medical, Inc. Barb configurations for barbed sutures
AU2003283410A1 (en) 2002-11-22 2004-06-18 Grunenthal Gmbh Combination of selected analgesics and cox-ii inhibitors
ATE342722T1 (de) 2003-05-07 2006-11-15 Osteologix As Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
US7205329B2 (en) 2003-05-30 2007-04-17 Microbia, Inc. Modulators of CRTH2 activity
US20070293542A1 (en) * 2003-10-16 2007-12-20 Cali Brian M Selective Cox-2 Inhibitors
CA2566438C (en) 2004-05-14 2014-12-09 Angiotech Pharmaceuticals, Inc. Suture methods and devices
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
SE532177C2 (sv) * 2006-07-24 2009-11-10 P & P Ab En punkteringsanordning för en uppblåsbar enhet
KR20090054984A (ko) 2006-08-07 2009-06-01 아이언우드 파마슈티컬스, 인코포레이티드 인돌 화합물
US20080255612A1 (en) 2007-04-13 2008-10-16 Angiotech Pharmaceuticals, Inc. Self-retaining systems for surgical procedures
US8777987B2 (en) 2007-09-27 2014-07-15 Ethicon, Inc. Self-retaining sutures including tissue retainers having improved strength
US8916077B1 (en) 2007-12-19 2014-12-23 Ethicon, Inc. Self-retaining sutures with retainers formed from molten material
US8118834B1 (en) 2007-12-20 2012-02-21 Angiotech Pharmaceuticals, Inc. Composite self-retaining sutures and method
EP2249712B8 (en) 2008-02-21 2018-12-26 Ethicon LLC Method and apparatus for elevating retainers on self-retaining sutures
CN102056552B (zh) 2008-04-15 2013-07-03 伊西康有限责任公司 具有双向保持器或单向保持器的自保持缝合线
AR073277A1 (es) * 2008-09-05 2010-10-28 Gruenenthal Gmbh Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol, y uso
KR20110065488A (ko) * 2008-09-05 2011-06-15 그뤼넨탈 게엠베하 6-디메틸아미노메틸-1-(3-메톡시-페닐)-사이클로헥산-1,3-디올 및 ｎｓａｉｄ를 포함하는 약제학적 병용물
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
EP3420923A1 (en) 2008-11-03 2019-01-02 Ethicon, LLC Length of self-retaining suture and device for using the same
EP2311446A1 (en) * 2009-10-16 2011-04-20 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising Tramadol and Celecoxib in the treatment of pain
SI2488169T1 (sl) * 2009-10-16 2013-05-31 Laboratorios Del Dr. Esteve, S.A. Ko - kristali iz tramadola in koksibov
WO2011090628A2 (en) 2009-12-29 2011-07-28 Angiotech Pharmaceuticals, Inc. Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods
EP2353594A1 (en) 2010-02-09 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising tramadol and the co-crystal of celecoxib and L-proline in the treatment of pain
KR102045300B1 (ko) 2010-05-04 2019-11-18 에티컨, 엘엘씨 레이저 커팅된 리테이너를 갖는 자가-유지형 시스템
EP2392319A1 (en) * 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs
BR112012031606B1 (pt) 2010-06-11 2020-11-10 Ethicon Llc distribuidor de sutura
CN103747746B (zh) 2010-11-03 2017-05-10 伊西康有限责任公司 药物洗脱自固位缝合线及其相关方法
CA2817036C (en) 2010-11-09 2019-01-15 Ethicon, Llc Emergency self-retaining sutures and packaging
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
CA2830961C (en) 2011-03-23 2018-12-04 Ethicon, Llc Self-retaining variable loop sutures
US20130172931A1 (en) 2011-06-06 2013-07-04 Jeffrey M. Gross Methods and devices for soft palate tissue elevation procedures
MX2016006464A (es) * 2016-05-18 2017-11-17 Laboratorios Liomont S A De C V Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
CN117017971A (zh) * 2017-09-15 2023-11-10 晶体基因技术株式会社 用于治疗急性或慢性疼痛的药物组合物
MX2018013070A (es) 2017-12-29 2019-10-15 Gruenenthal Gmbh Combinación farmacéutica que comprende clorhidrato de tramadol de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor.
KR102631399B1 (ko) 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
JP2636819B2 (ja) * 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
TR199900298T2 (xx) * 1996-08-14 1999-05-21 G.D. Searle &Co. 4-(5-Metil-3-fenilizoksazol-4-il) BenzenS�lfonamidin kristal halinde bi�imi.
US5919826A (en) * 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
AU7472798A (en) * 1997-05-07 1998-11-27 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
AU1398899A (en) * 1998-11-12 2000-06-05 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics

Also Published As

Publication number Publication date
AU3384200A (en) 2000-09-21
CA2364127A1 (en) 2000-09-08
NZ513924A (en) 2001-09-28
JP2002538176A (ja) 2002-11-12
WO2000051685A1 (en) 2000-09-08
CN1349423A (zh) 2002-05-15
EP1156855A1 (en) 2001-11-28
MXPA01008903A (es) 2003-07-21

Similar Documents

Publication Publication Date Title
NZ513924A (en) Composition comprising a tramadol material and a selective cox-2 inhibitor drug
IL148019A0 (en) Composition comprising a tramadol material and an anticonvulsant drug
IS5794A (is) Lyfjasamsetning sem inniheldur COX-2-hemil og iNOS-hemil
GB0021882D0 (en) Combining material and data
HK1084716A1 (en) A holding and sealing mat material
IL150418A0 (en) Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
HUP0301868A3 (en) Pharmaceutical composition comprising a factor viia and a factor xiii
HUP0203728A3 (en) Aerosol composition comprising formoterol
EP1340728A4 (en) BUILDING MATERIAL AND CONNECTION FOR THIS
EP1079034A4 (en) JOINING MATERIAL AND METHOD FOR MANUFACTURING SAID MATERIAL
GB0004016D0 (en) Biological material and uses thereof
GB2396815B (en) A composition comprising a pregnenone derivative and an NSAID
GB0022617D0 (en) Recording material and method
PL352387A1 (en) Pharmaceutical composition containing sibutramine and a lipase inhibitor
AU2001294058A1 (en) A rotary soil engaging member and a material for use therein
GB0224848D0 (en) Packaging and packaging material
HUP0302371A3 (en) New pharmaceutical composition comprising a betablocker and optionally a cholesterol-lowering agent
DE60026493D1 (en) Blattförmiges photohärtbares material
GB9901897D0 (en) Biological material and use thereof
HUP0500955A3 (en) Cucurbitacin-containing insecticidal composition and a process for its use
GB9907469D0 (en) Labels and manufacture thereof
DK1210118T3 (da) Sammensætning omfattende et tramadolmateriale og et antikonvulsionslægemiddel
GB9927769D0 (en) Biological material and uses thereof
HK1029961A1 (en) A building material and its houses.